Abstract:OBJECTIVE:To investigate the molecular mechanism of adiponectin inhibiting activation of hepatic stellate cells in non-alcoholic fatty liver fibrosis.METHODS:The rat models of non-alcoholic fatty liver fibrosis were successfully established by fat-rich diet administration. The expression of adiponectin mRNA and protein were respectively detected by reverse transcription-polymerase chain reaction (RT-PCR) and Western blot. LX-2 cells were cultured in an adipogenic differentiation mixture to induce quiescent adipocytic phenotypes, and then they were treated with TGFβ1, adiponectin and TGFβ1 + adiponectin, respectively. RT-PCR and Western blot were used to determine the expressions of mRNAs and proteins of a-smooth muscle actin (a-SMA), Collagen, adenosine monophosphate-activated protein kinase (AMPK), inducible nitric oxide synthase (iNOS), and endothelial NOS (eNOS). The results were analyzed using one-way ANOVA, Student-Newman-Keuls test, and linear correlation analysis. A P value of less than 0.05 was considered as statistically significant.RESULTS:In vivo, with the progress of non-alcoholic fatty liver fibrosis, the model rats gradually showed hepatic steatosis, inflammation, necrosis and fibrosis. Compared with the control group, the level of serum adiponectin (2.49 ± 0.86 vs 5.81 ± 0.87, P < 0.05) and hepatic expressions of adiponectin mRNA and protein (0.26 ± 0.04 vs 0.72 ± 0.08; 0.64 ± 0.07 vs 0.21 ± 0.07, all P < 0.05) were all decreased in the 24th week group, and were negatively correlated with the level of Collagen which increased gradually. In vitro, TGFβ1 could activate quiescent LX-2 cells by decreasing mRNA and protein expression of eNOS (0.30 ± 0.10 vs 0.44 ± 0.08; 0.30 ± 0.09 vs 0.46 ± 0.07, all P < 0.05) and increasing the expression of iNOS (0.53 ± 0.07 vs 0.37 ± 0.04; 0.55 ± 0.07 vs 0.39 ± 0.05, all P < 0.05). Recombinant adiponectin not only maintained the quiescent phenotype of LX-2 cells but also inhibited LX-2 cells activation due to TGFβ1 by increasing the expression of eNOS (0.43 ± 0.08 vs 0.30 ± 0.10; 0.42 ± 0.07 vs 0.30 ± 0.09, all P < 0.05) and phosphorylation of AMPK (0.43 ± 0.07 vs 0.24 ± 0.04, P < 0.05) and decreasing the expression of iNOS (0.44 ± 0.05 vs 0.53 ± 0.07; 0.46 ± 0.07 vs 0.55 ± 0.07, all P < 0.05).CONCLUSIONS:Data suggested that adiponectin could play a protective role on the pathogenesis of non-alcoholic fatty liver fibrosis by inhibiting the activation of hepatic stellate cells via up-regulating the expression of eNOS, which might associate with increased phosphorylation of AMPK.

Adiponectin Deficiency Impairs Liver Regeneration Through Attenuating STAT3 Phosphorylation in Mice

Apolipoprotein A-1 Accelerated Liver Regeneration Through Regulating Autophagy Via AMPK-ULK1 Pathway.

CREBZF as a Key Regulator of STAT3 Pathway in the Control of Liver Regeneration in Mice

Defective Initiation of Liver Regeneration in Osteopontin-Deficient Mice after Partial Hepatectomy Due to Insufficient Activation of IL-6/Stat3 Pathway.

Retraction Note: Adiponectin Deficiency Rescues High-Fat Diet-Induced Hepatic Injury, Apoptosis and Autophagy Loss Despite Persistent Steatosis

[Adiponectin Inhibits the Activation of Hepatic Stellate Cells Induced by TGFb1 Via Up-Regulating the Expression of Enos].

Regulation Of Insulin Resistance And Adiponectin Signaling In Adipose Tissue By Liver X Receptor Activation Highlights A Cross-Talk With Ppar Gamma

Deficiency of Apoptosis-Stimulating Protein Two of P53 Promotes Liver Regeneration in Mice by Activating Mammalian Target of Rapamycin

Adiponectin Inhibits Leptin Signalling Via Multiple Mechanisms to Exert Protective Effects Against Hepatic Fibrosis

Adiponectin Alleviates Diet-Induced Inflammation in the Liver by Suppressing MCP-1 Expression and Macrophage Infiltration

Myeloid Peroxisome Proliferator-Activated Receptor Α Deficiency Accelerates Liver Regeneration Via IL-6/STAT3 Pathway after 2/3 Partial Hepatectomy in Mice

Deficiency of Periostin Impairs Liver Regeneration in Mice after Partial Hepatectomy

Adiponectin Inhibits NLRP3 Inflammasome Activation in Nonalcoholic Steatohepatitis via AMPK-JNK/ErK1/2-NFκB/ROS Signaling Pathways

Suppression of YAP/TAZ-Notch1-NICD axis by bromodomain and extraterminal protein inhibition impairs liver regeneration.

APPL1-mediated Activation of STAT3 Contributes to Inhibitory Effect of Adiponectin on Hepatic Gluconeogenesis

Adiponectin inhibits palmitic acid-induced NLRP3 inflammasome activation in hepatocytes through AMPK-JNK/ErK1/2-NFκB/ROS signaling pathways

Defective endoplasmic reticulum stress response via X box‐binding protein 1 is a major cause of poor liver regeneration after partial hepatectomy in mice with non‐alcoholic steatohepatitis

Enhanced liver regeneration in IL10 deficient mice after partial hepatectomy via activating hepatocyte STAT3 and stimulating inflammatory response (134.6)

Adipose Tissue Transplantation Ameliorates Lipodystrophy-Associated Metabolic Disorders in Seipin-Deficient Mice

Angiogenic deficiency and adipose tissue dysfunction are associated with macrophage malfunction in SIRT1-/- mice.

Correlation of Serum Adiponectin Level and Adiponectin Receptor Expression with Hepatic Pathological Changes in Rats with Non-Alcoholic Fatty Liver Diseases